Company: SXTPW
Filing Date: 2025-09-05
Form Type: 8-K
Source: 0001213900-25-085040
Chunk: 3

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-05
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits

(a) Exhibits

  Number      Description                                                                                                                        
     1.1      Sales Agreement, dated as of September 5, 2025, by and among the 60 Degree Pharmaceuticals, Inc. and H. C. Wainwright & Co., LLC,  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     5.1      Opinion of Sichenzia Ross Ference Carmel LLP                                                                                       
    23.1      Consent of Sichenzia Ross Ference Carmel LLP (included in the opinion filed as Exhibit 5.1)                                        
     104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                        

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                               60 DEGREES PHARMACEUTICALS, INC.                                             
  Date: September 5, 2025      By:                                   /s/ Geoffrey Dow                       
                               Name:                                 Geoffrey Dow                           
                               Title:                                Chief Executive Officer and President